Program workshopu

Sunday 6.4.2025

13.30 – 14.30 Advisory board 1 – Bristol Myers Squibb - Invited only                                           (Pálava Lounge)

14.30 – 15.30 Advisory board 2 – Pfizer - Invited only                                                                   (Pálava Lounge)

15.30 – 16.00 Coffee break

16.00 – 17:00 Advisory board 3 – GlaxoSmithKline - Invited only                                                 (Pálava Lounge)

17.00 – 18.30 CMG board meeting - Closed meeting for CMG board and invited guests            (Pálava Lounge)

19.00 Dinner 

Monday 7.4.2025

Morning business meetings:

8.00 – 9.00 Advisory board 4 – Johnson & Johnson - Invited only                                             (Pálava Lounge)

9.00 – 10.00 CMG board meeting + participating centers - Closed session                                (Pálava Lounge)

Working groups meetings (open sessions):

10.00 – 12.00 Flow cytometry working group                                                                                 (Pálava Lounge)

Coordinator: O.Souček/O.Venglář

10.00 – 12.00 Diagnostic methods working group – genomics and cytogenetics                (Frankovka Lounge)

Coordinator: J.Kotašková/T.Ševčíková

10.00 – 12.00 Biochemical methods working group                                                                        (Müller Lounge)

Coordinator: P.Kušnierová/A.Tomášová

10.00 – 12.00 Imaging in myeloma working group                                                                      (Thurgau Lounge)

Coordinator: M.Havel

Data management education session (parallel to main program):

9.00 – 12.00 Data management session                                                                                   (Sauvignon Lounge)

Chair: J.Kopečková, V.Maisnar, M.Štork

12.00 – 12.45 Lunch break

12.45 – 13.45 Challenge your anti-CD38 expectations in non-transplant NDMM (Sanofi satellite symposium)                                                                                                                                                                      (Aurelius Hall)

13.45– 14.30 ROUNDTABLE DISCUSSION

New definition of high-risk & Approach to standard or high-risk newly diagnosed multiple myeloma

Chair: M.Štork (Brno)

Panelists: M.Mohty, J. Radocha, R.Hájek, T.Ševčíková, S.Ševčíková, K.Menšíková

14.45 – 15.30 EDUCATION SECTION

Molecular basis of high-risk myeloma – which method to use in 2025?

Chair: T.Stopka (Praha)

NGS analysis in multiple myeloma patients - CZ Real World Evidence data – J. Kotašková (Brno)

CTCs in multiple myeloma patients – O. Venglář (Ostrava)

Panel discussion

Panelists: M.Štork, J.Radocha, J.Kotašková, O.Venglář.

15.30 – 16.00 Coffee break

16.00 – 17.00 Raising new horizon for MM (Johnson & Johnson satellite symposium)

17.00 – 17.45 ROUNDTABLE DISCUSSION

New criteria for response assessment

Chair: R.Hájek (Ostrava)

Panelists: P.Sonneveld, L.Pour, J.Minařík, I.Špička, J.Radocha, L.Muroňová

18.00 – 18.45 EDUCATION SECTION

Hemostasis disorders in multiple myeloma

Chair: J.Gumulec (Ostrava)

Disorders of hemostasis in multiple myeloma patients: Stay Alert, J.Gumulec (Ostrava)

Drug-induced thrombotic microangiopathy in a patient with multiple myeloma, D.Buffa (Ostrava)

Prophylaxis of venous thromboembolism in patients with multiple myeloma: Update 2025, P.Kessler (Pelhřimov)

19.30 Evening ceremony of the 23rd Workshop                                                                                 (Aurelius Hall)

19.30 – 20.30 Prof. Otto Kahler Award – Pieter Sonneveld

Introduced by R.Hájek (Ostrava)

21.00 - 02.00 Social evening                                                                                                                  (hotel Galant)

Tuesday 8.4.2025

08.00 – 8.30 Annual meeting of CMG members (CZ)                                                                        (Aurelius Hall)

Chairs: R.Hájek (Ostrava), M.Krejčí (Brno)

• Annual report (R.Hájek, Ostrava)
• Steering committee report (M.Krejčí, Brno)

8.30 – 9.00 Working group reports – 5 minutes each working group

9.00 – 10.00 ELREXFIO – directed BCMA of multiple myeloma treatment (Pfizer satellite symposium)

Chair: doc. MUDr. Jakub Radocha, Ph.D. (Hradec Králové)

MagnetisMM-3: Data update, MUDr. Martin Štork, Ph.D., Fakultní nemocnice Brno

CRS, Hospitalization, and Quality of life, doc. MUDr. Jakub Radocha, Ph.D.; Fakultní nemocnice Hradec Králové

Infections, Albert Oriol, MD, Ph.D.; Institut Català d'Oncologia in Hospital Germans Trias i Pujol and the Clinical Research Support Unit in the Badalona location of the Josep Carreras Institute, Spain

10.00 – 10.45 ROUNDTABLE DISCUSSION

Therapy cessation - when, why, to whom?

Chair: J.Radocha (Hradec Králové)

Panelists: A.Oriol, L.Pour, L.Muroňová, P.Pavlíček, J.Minařík

10.45 – 11.15 Photo shooting + Coffee break

11.15 – 12.00 YOUNG BLOOD IN MYELOM

Chair: J.Minařík (Olomouc)

Why, when and how using PET/CT to evaluate response in multiple myeloma, L.Muroňová (Ostrava)

MRD assessment in extraosseous multiple myeloma, N.Sendlerová (Brno)

CAR-T cells toxicity in newly diagnosed multiple myeloma patients in CZ, M.Horňáková (Ostrava)

12.00 – 12.45 ACTIVITIES FOR PHYSICIANS AND PATIENTS

Chair: A.Onderková (Brno), R.Hájek (Ostrava)

The impact of multiple myeloma on patients, their surroundings, and society as a whole, T.Doležal

Patient Support and Advocacy: National European Collaborations, K.Joyner

12.45 - 13.45 ABECMA v léčbě mnohočetného myelomu (Bristol Myers Squibb satellite symposium)

13.45 - 14.00 Closing comments and farewell (R. Hájek, Ostrava)

14.00 Lunch break

Permanent poster sections in foyer:

I. CMG Activities in the Given Year & Major Congresses

II. Patients' activities in the Given Year & Multiple Myeloma Patient Club